Lipid-altering drugs: decreasing cardiovascular disease at the expense of increasing cancer?
Goldstein
Mark R
MR
Murao
Koji
K
Imachi
Hitomi
H
Ishida
Toshihiko
T
Wong
Norman C W
NC
D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000097:blood; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL